The resilience of the pharmaceutical sector masked much deeper problems in the Swiss manufacturing sector in Q2, but signs that German industry continued to rebound in August bode well given strong supply-chain links. Next week, the first estimates of Q2 GDP from Norway and Switzerland are likely to add to the evidence that Switzerland and the Nordic economies got off pretty lightly by European standards.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.